Archive - February 2018
Tennessee seeks $250 million in uncompensated-care funds
Newer psoriasis drugs top the old, but it’s not efficacy that counts. It’s payer negotiations: analyst
Treatment-resistant depression doubles patient healthcare costs
Loyola health system CEO takes job out West
Mercy Health and Bon Secours to merge
Amgen sued FDA for a 6-month reprieve from Sensipar generics—and lost
Plant where Biocon and Mylan will produce their Lantus copy spanked with FDA Form 483
Patients Report Rare and Mysterious Side Effects With Blockbuster Eye Drug